Vorapaxar Sulfate

Vorapaxar Sulfate

Vorapaxar (trade name: Zontivity) is a thrombin receptor (protease-activated receptor, PAR-1) antagonist. Vorapaxar is a new anti-platelet drug that and is used for persons with a history of myocardial infarction (heart attack) or persons with peripheral arterial disease. Vorapaxar has been approved by the U.S Food and Drug Administration on May 5, 2014.

Specifications

Product Name:                  Vorapaxar Sulfate

Synonyms:                         SCH 530348

CAS Number:                     705260-08-8

Molecular Weight:            590.6625

Molecular Formula:          C29H35FN2O8S

Purity (HPLC):                     ≥99%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               OS(=O)(=O)O.CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]1[C@H]([C@H]2/C=C/c2ccc(cn2)c2cccc(c2)F)[C@H](O

  • $700.00
  • Ex Tax: $700.00

Available Options